Cardiology CME

Meetings By Mail presents the ALL NEW Vascular Imaging Educators Workshop (VIEW), featuring twenty hours of exceptional content dedicated to the diagnosis and treatment of vascular disease.  Provided by the Society for Vascular Ultrasound through its 43rd Annual Conference, this activity delivers a complete educational experience for all vascular laboratory professionals.  Worth 20 AMA PRA Category I Credits™, VIEW MEETS VASCULAR LAB CME REQUIREMENTS FOR ACCREDITATION.

The Society of Radiologists in Ultrasound (SRU) has promoted the science, practice and teaching of sonography for over three decades. Its 31st Annual Meeting, features nearly eighty expert faculty members providing a detailed update and review of all facets of ultrasound.  As such, this activity is an essential resource for all that are interested in this constantly evolving modality.  Its content will help radiologists maintain their leadership in clinical ultrasound imaging, by providing insight in new technology and techniques.  The SRU 31st Annual Meeting is worth 35 AMA PRA Category I Credits™, which fulfills ABR Self Assessment CME requirements for Maintenance of Certification (MOC). Additionally, this activity meets the ACR CME requirement for accreditation in Ultrasound.

Target Audience: Physicians specializing in Cardiology, Chest Medicine, Family Medicine, Internal Medicine.

Activity Description / Statement of Need:
In this online, self-learning activity:

Transthyretin-mediated amyloidosis (ATTR) is a progressive, multisystem, life-threatening disorder characterized by the extracellular deposition of misfolded, insoluble amyloid fibrils. The role of the TTR protein is to transport thyroxine and retinol-binding proteins, and it is vital for cognition, nerve regeneration, and axonal growth. TTR itself is innately amyloidogenic even without the presence of genetic mutations, which may account for wild-type ATTR (wtATTR), while a hereditary form of ATTR (hATTR) may be passed to offspring through autosomal dominant inheritance. Left untreated, the average life expectancy of ATTR is 3 to 15 years from symptom onset.

Target Audience:
The following HCPs: neurologists, cardiologists, and hematologists; physician assistants, nurse practitioners, and pharmacists in the aforementioned areas of specialty; and any other HCPs with an interest in or who may clinically encounter patients with ATTR.

Activity Description / Statement of Need:
In this online, self-learning activity:

Familial chylomicronemia syndrome (FCS) is an ultrarare genetic disease characterized by the buildup of chylomicrons – the largest lipoprotein – as a result of loss of function of one of five genes responsible for lipolysis. Its estimated prevalence is one in one million people and affects patients of all ages. The clinical presentation of FCS varies but includes patients with triglyceride (TG) levels over 10 times and up to a hundred-fold times the upper limit of normal. Complications include eruptive xanthomas on the trunk and extremities, lipemia retinalis, recurrent abdominal pain, hepatosplenomegaly, fatigue, cognitive disorientation, organ failure, necrosis, and pancreatitis, the latter of which is associated with a five- to 30-percent mortality rate in patients affected by FCS. Unfortunately, due in part to the rarity of the condition, patients are commonly undiagnosed, even by endocrinologists.

Target Audience:
HCPs including: endocrinologists, cardiologists, and primary care physicians; physician assistants, nurse practitioners, and pharmacists who practice in the aforementioned areas of specialty; and those who otherwise have an interest in or commonly care for or clinically encounter patients with FCS.

Learn Now: Thrombosis CME from the Experts

This online CME course from the North American Thrombosis Forum provides a comprehensive review of the most significant changes and advances impacting the care of patients who have — or are at risk for — thrombotic disorders. World-renowned experts and leading clinical faculty share key updates on the prevention, diagnosis, and treatment of thrombosis and related conditions.

Thrombosis and Thromboembolism is continuing medical education that will help you to:

• Identify the etiology and pathophysiology of atherothrombosis
• Recognize the link between inflammation and thrombotic illnesses
• Explain new tools for stroke prevention and prediction in atrial fibrillation
• Identify the optimal duration of anticoagulation for PE and DVT
• Provide advanced therapies such as thrombolysis, catheter-directed therapy, and surgical embolectomy
• Explain the connection between diabetes, metabolic syndrome, and major adverse cardiac events
• Provide patients with useful insights into how a heart-healthy diet can help prevent thrombosis
• Manage a high-risk pregnancy
• And more…

Activity Description / Statement of Need:

In this online, self-learning activity:

Heart failure (HF) is a clinical syndrome arising from diminished ventricular filling or ejection of blood. HF with reduced ejection fraction (HFrEF) is characterized by abnormality in the systolic function and a left ventricular ejection fraction (LVEF) of <40%. The prevalence of HF is about 40 million people globally and approximately 6.5 million in the U.S., and as the global population continues to age, the prevalence of HF is expected to continue increasing over the coming decades. HFrEF constitutes a major public health concern, with five-year survival rates as low as 25%, and it carries with it a significant risk of emergency department visits and hospitalizations.

There has been increased focus recently on guideline-directed medical therapy (GDMT) in HFrEF, and evidence suggests that each ten percent improvement in measures of guideline-recommended composite care is associated with a thirteen percent lower odds of 24-month mortality. Nonetheless, research shows that substantial portions of patients are not treated with guideline-recommended doses, even after taking into account dose-limiting physiological parameters, and that guideline non-adherent practice is associated with poorer outcomes.

Target Audience:

The following HCPs: Cardiologists and PCPs; physician assistants, nurse practitioners, and pharmacists who practice in cardiology; and any other HCPs with an interest in or who clinically encounter patients with HFrEF.

Evidence-Based Cardiology CME: Strategies for ACHD

Adults with congenital heart disease (ACHD) are a rapidly growing, frequently underserved population who present new challenges in cardiology patient management. In this online video CME course, presenters address the latest clinical and research advances in congenital anomaly morphologies.

Evidence-based lectures focus on the best diagnostic modalities and interventions, as well as the most appropriate management strategies. You get continuing medical education that will improve your ability to:

• Assess right ventricular outflow tract reconstruction, including clinical evaluation and interventional, surgical, and hybrid options
• Assess and manage adults who underwent Fontan surgery, including imaging, treatment options, and timing of valve interventions, Fontan conversion, and heart failure therapies
• Assess and treat patients with Fontan-associated liver disease
• Recognize social and patient-perceived barriers that complicate the diagnosis and life-long management of ACHD
• Detail the highly complex ecosystem of adult congenital heart care and describe how new guidelines may shape care in the future